Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: A follow-up of the Eastern Cooperative Oncology Group E3A98 trial

Morie A. Gertz, Rafat Abonour, Leonard T. Heffner, Philip R. Greipp, Hajime Uno, S. V. Rajkumar

Research output: Contribution to journal › Article › peer-review

39 Scopus citations

Fingerprint

Dive into the research topics of 'Clinical value of minor responses after 4 doses of rituximab in Waldenström macroglobulinaemia: A follow-up of the Eastern Cooperative Oncology Group E3A98 trial'. Together they form a unique fingerprint.

Medicine & Life Sciences